123 related articles for article (PubMed ID: 37419428)
1. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
Kiani Ghalesardi O; Zaker F; Ghotaslou A; Boustani H; Rezvani MR; Kiani J; Shahidi M
Gene; 2023 Sep; 880():147622. PubMed ID: 37419428
[TBL] [Abstract][Full Text] [Related]
2. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
[TBL] [Abstract][Full Text] [Related]
3. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
[TBL] [Abstract][Full Text] [Related]
5. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
6. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
Link PA; Baer MR; James SR; Jones DA; Karpf AR
Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910
[TBL] [Abstract][Full Text] [Related]
7. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.
Guittet O; Tebbi A; Cottet MH; Vésin F; Lepoivre M
Nitric Oxide; 2008 Sep; 19(2):84-94. PubMed ID: 18474260
[TBL] [Abstract][Full Text] [Related]
10. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
11. E2F1 regulates p53R2 gene expression in p53-deficient cells.
Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
[TBL] [Abstract][Full Text] [Related]
12. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
Al-Aamri HM; Ku H; Irving HR; Tucci J; Meehan-Andrews T; Bradley C
BMC Cancer; 2019 Feb; 19(1):179. PubMed ID: 30813936
[TBL] [Abstract][Full Text] [Related]
13. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
14. Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis.
Tebbi A; Guittet O; Tuphile K; Cabrié A; Lepoivre M
J Biol Chem; 2015 May; 290(22):14077-90. PubMed ID: 25878246
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
[TBL] [Abstract][Full Text] [Related]
16. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
[TBL] [Abstract][Full Text] [Related]
17. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
[TBL] [Abstract][Full Text] [Related]
18. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Cancer Lett; 2003 Feb; 190(2):233-43. PubMed ID: 12565178
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
